Pretreatment neutrophil-to-lymphocyte ratio is a predictive biomarker for EGFR TKI-treated patients with advanced EGFR-mutant Non-small cell lung cancer

BACKGROUND: Neutrophil-lymphocyte ratio (NLR) has been reported as a prognostic biomarker in various cancers, but its prognostic value for advanced epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) treated with EGFR tyrosine kinase inhibitors (TKIs) remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Cong, Yao, Xiaojun, Li, Ting, Wang, Jue, An, Bo, Wang, Jing, Sui, Xinbing, Leung, Elaine Lai-Han, Wu, Qibiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797611/
https://www.ncbi.nlm.nih.gov/pubmed/35117644
http://dx.doi.org/10.21037/tcr.2020.02.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797611/
https://www.ncbi.nlm.nih.gov/pubmed/35117644
http://dx.doi.org/10.21037/tcr.2020.02.28

Ejemplares similares